pyridostigmine bromide has been researched along with concanavalin a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, CT; Dudley, AC; EuDaly, JG; Gilkeson, GS; Keil, DE; Peden-Adams, MM | 1 |
1 other study(ies) available for pyridostigmine bromide and concanavalin a
Article | Year |
---|---|
Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice.
Topics: Administration, Oral; Animals; Antibody Formation; Body Weight; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Count; Concanavalin A; Cytotoxicity, Immunologic; Dexamethasone; Erythrocytes; Female; Immunity; Immunity, Cellular; Killer Cells, Natural; Lipopolysaccharides; Lymphocyte Activation; Mice; Organ Size; Polychlorinated Dibenzodioxins; Pyridostigmine Bromide; Spleen; Thymus Gland; Vaccination | 2004 |